According to the 4th edition of the WHO classification of tumors of the lung, pleura, thymus and heart, the positive rates of CD5 and CD117 in thymic squamous cell carcinoma are 74% and 84%, respectively [1]. The gene discussed is CD5; the disease is thymus squamous cell carcinoma.